摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

trans-1-(3-cyanophenyl)prop-1-ene | 74254-14-1

中文名称
——
中文别名
——
英文名称
trans-1-(3-cyanophenyl)prop-1-ene
英文别名
3-[(E)-prop-1-enyl]benzonitrile
trans-1-(3-cyanophenyl)prop-1-ene化学式
CAS
74254-14-1
化学式
C10H9N
mdl
——
分子量
143.188
InChiKey
KAJJDIGDGBWEHP-DUXPYHPUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    247.1±19.0 °C(Predicted)
  • 密度:
    1.00±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    23.8
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    trans-1-(3-cyanophenyl)prop-1-ene 在 palladium on activated charcoal lithium aluminium tetrahydride 、 氢气 作用下, 生成 3-n.propylbenzylamine
    参考文献:
    名称:
    De Amici; De Micheli; Pratesi, Farmaco, Edizione Scientifica, 1987, vol. 42, # 6, p. 409 - 424
    摘要:
    DOI:
  • 作为产物:
    描述:
    3-烯丙基苯甲腈 在 nickel(II) iodide 、 6,6'-二甲基-2,2'-联吡啶亚磷酸二乙酯 作用下, 以 N,N-二甲基乙酰胺 为溶剂, 反应 24.0h, 以82%的产率得到trans-1-(3-cyanophenyl)prop-1-ene
    参考文献:
    名称:
    一种E式甲基苯乙烯类化合物的合成方法
    摘要:
    一种由烯丙基型苯异构成E式烷基苯乙烯类化合物的方法,它是在氮气保护下,将丙烯基型苯在金属镍盐、配体和添加剂存在下,在溶剂中,在0℃~50℃反应24‑36h,即得E式烷基苯乙烯类化合物,所述的配体是2,2’‑联吡啶或烷基取代的2,2’‑联吡啶;所述的添加剂是锰粉、锌粉、亚磷酸二乙酯、苯基亚磷酸乙酯、乙酸的一种或多种。本发明的制备方法具有方法简单,原料便宜、易得,操作简便等优点。
    公开号:
    CN110878012A
点击查看最新优质反应信息

文献信息

  • THIENOTRIAZOLODIAZEPINE COMPOUND AND MEDICINAL USE THEREOF
    申请人:Adachi Kunitomo
    公开号:US20100041643A1
    公开(公告)日:2010-02-18
    [Solving means] A thienotriazolodiazepine compound of the following formula (I) a pharmaceutical agent containing the compound as an active ingredient, and a production intermediate and a production method of the thienotriazolodiazepine compound. [Effect]Since this compound has an inhibitory action on costimulatory signal from CD28 on T cell, it is useful for the prophylaxis or suppression of rejection reaction in transplantation of organ or bone marrow and the like, and the prophylaxis or treatment of autoimmune diseases or allergic diseases.
    【解决方法】以下式(I)的噻唑三唑二氮杂环化合物,以其为活性成分的药物制剂,以及噻唑三唑二氮杂环化合物的生产中间体和生产方法。 【效果】由于该化合物对T细胞上的CD28共刺激信号具有抑制作用,因此它对于预防或抑制器官或骨髓移植等排斥反应,以及预防或治疗自身免疫性疾病或过敏疾病非常有用。
  • BENZODIAZEPINE COMPOUND AND PHARMACEUTICAL COMPOSITION
    申请人:Oshima Kunio
    公开号:US20130040941A1
    公开(公告)日:2013-02-14
    The present invention provides a novel benzodiazepine compound that blocks the I Kur current or the Kv1.5 channel potently and more selectively than other K + channels. The benzodiazepine compound of the invention is represented by General Formula (1) wherein R 1 , R 2 , R 3 , and R 4 are each independently hydrogen or lower alkyl; R 2 and R 3 may be linked to form lower alkylene; A 1 is lower alkylene optionally substituted with one or more hydroxy; and R 5 is group represented by wherein R 6 and R 7 are each independently hydrogen or organic group; X A and X B are each independently bond, lower alkylene, etc.
    本发明提供了一种新型苯二氮平化合物,能够有效地阻断IKur电流或Kv1.5通道,比其他K+通道更具选择性。本发明的苯二氮平化合物由通式(1)表示,其中R1、R2、R3和R4各自独立地为氢或低碳基;R2和R3可以连接形成低碳链;A1为低碳链,可选地取代一个或多个羟基;R5为由下式表示的基团:其中R6和R7各自独立地为氢或有机基团;XA和XB各自独立地为键,低碳链等。
  • THIENOTRIAZOLODIAZEPINE COMPOUND AND A MEDICINAL USE THEREOF
    申请人:Mitsubishi Tanabe Pharma Corporation
    公开号:EP1887008B1
    公开(公告)日:2021-04-21
  • Singlet State Cis,Trans Photoisomerization and Intersystem Crossing of 1-Arylpropenes
    作者:Frederick D. Lewis、Dario M. Bassani、Richard A. Caldwell、David J. Unett
    DOI:10.1021/ja00102a014
    日期:1994.11
    The temperature dependence of the singlet state lifetime and photoisomerization and fluorescence quantum yields for trans- and cis-1-phenylpropene have been determined in hexane solution. Calculated barriers for twisting about the double bond on the singlet potential energy surface are 8.8 and 4.6 kcal/mol for the trans and cis isomer, respectively. The barrier for the trans isomer is sufficiently high to prevent isomerization on the singlet state surface at or below room temperature. However, isomerization occurs at low temperatures as a consequence of intersystem crossing to the triplet state, which undergoes barrierless isomerization. The quantum yield for intersystem crossing, as determined by time-resolved photoacoustic calorimetry, is 0.60 +/- 0.03 and the rate constant for intersystem crossing is 4.7 x 10(7) s(-1). While internal conversion is not significant at or below room temperature, thermally activated internal conversion competes with singlet isomerization at high temperatures. The cis isomer undergoes isomerization predominantly via the singlet state at room temperature. Both electron-donating (p-methoxy) and electron-withdrawing (m- and p-cyano, p-carbomethoxy, and p-trifluormethyl) aromatic substituents are found to lower the barrier for singlet state isomerization. Increased solvent polarity (acetonitrile vs hexane) results in variable decreases in the barrier for singlet state isomerization. Photoisomerization of the p-cyano derivative at room temperature occurs predominantly via the triplet state in hexane solution and via the singlet state in acetonitrile solution. The effects of substituents and solvent are better correlated with the magnitude of the S-2-S-1 energy gap than the stability of either zwitterionic or biradical intermediates. Rate constants for intersystem crossing are, in most cases, not highly dependent upon aromatic substitution or solvent polarity.
  • TYROSINE DERIVATIVES
    申请人:GENENTECH, INC.
    公开号:EP1214292B1
    公开(公告)日:2007-06-13
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐